发明名称 Hepatitis C virus polymerase inhibitors
摘要 The invention provides a compound of formula: and methods for making and using the same, where R<SUP>1 </SUP>and R<SUP>2 </SUP>are independently hydrogen, C<SUB>1-6 </SUB>alkyl or C<SUB>1-6 </SUB>haloalkyl; R<SUP>3 </SUP>is hydrogen, halogen, C<SUB>1-6 </SUB>alkyl or C<SUB>1-6 </SUB>alkoxy; R<SUP>4 </SUP>is hydrogen or halogen; and R<SUP>5 </SUP>is a mono- or di-amino acid moiety, a succinic acid moiety, a urea moiety, or a derivative thereof. The invention also provides pharmaceutical compositions comprising a compound of formula I, and methods for making and using the same.
申请公布号 US2008200512(A1) 申请公布日期 2008.08.21
申请号 US20080070027 申请日期 2008.02.14
申请人 BLANEY JEFFREY MARK;HEBERT NORMAND;HOPKINS STEPHANIE ANN;JEFFERSON ELIZABETH A;TOMIMOTO MASAKI 发明人 BLANEY JEFFREY MARK;HEBERT NORMAND;HOPKINS STEPHANIE ANN;JEFFERSON ELIZABETH A.;TOMIMOTO MASAKI
分类号 A61K31/445;A61P31/12;C07D211/60 主分类号 A61K31/445
代理机构 代理人
主权项
地址